Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Melanoma × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 53 Leukemia 35 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Lymphoma 19 Lymphoma, Large B-Cell, Diffuse 18 Lymphoma, Non-Hodgkin 13 Leukemia, Myelomonocytic, Acute 9 Leukemia, Monocytic, Acute 9 Lymphoma, Mantle-Cell 8 Leukemia, Megakaryoblastic, Acute 8 Leukemia, Erythroblastic, Acute 8 Recurrence 7 Burkitt Lymphoma 7 Myelodysplastic Syndromes 6 Lymphoma, Large-Cell, Immunoblastic 6 Lymphoma, Follicular 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Congenital Abnormalities 5 Leukemia, Myeloid, Chronic-Phase 4 Hodgkin Disease 4 Leukemia, Promyelocytic, Acute 3 Leukemia, Eosinophilic, Acute 3 Leukemia, Basophilic, Acute 3 Anemia, Refractory, with Excess of Blasts 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, T-Cell 2 Leukemia, Myelomonocytic, Chronic 2

Interventions

Nivolumab 22 pembrolizumab 16 Ipilimumab 13 Temozolomide 11 toripalimab 9 Biopsy 8 Dacarbazine 7 Blood Specimen Collection 7 Cyclophosphamide 6 trametinib 5 fludarabine 5 dabrafenib 5 camrelizumab 5 atezolizumab 5 durvalumab 4 binimetinib 4 aldesleukin 4 Interleukin-2 4 Injections 4 Gene Expression Profiling 4 Chemotherapy, Adjuvant 4 palbociclib 3 encorafenib 3 apatinib 3 Sorafenib 3 Introns 3 Cisplatin 3 Carboplatin 3 Canvaxin 3 Bevacizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡